Leading-edge assays enabling better medical decisions
ELITech Molecular Diagnostics is recognized for its industry leading PCR technologies, including Minor Groove Binder (MGB). Our products deliver superior sensitivity and specificity, enabling more accurate diagnoses for treatment and monitoring of organ transplant, opportunistic infections, infectious diseases, Healthcare Associated Infections, cancer and human genetics.
ELITech Molecular Diagnostics has pioneered developments in molecular diagnostics, bringing trusted results to laboratories, giving clinicians the tools to make better medical decisions and improve clinical outcomes.
Our patented technologies offer significant technological advantages over traditional methods including:
ELITech Molecular Diagnostics focuses its research and development efforts on creating innovative technologies and products that provide clinicians with advanced diagnostic capabilities. Superior performance and responsive customer support give us a leading position in the organ transplant market. Our proprietary Minor Groove Binder (MGB®), Superbase™ and Eclipse®Dark Quencher technologies significantly enhance PCR performance. Through collaborations with medical, academic and scientific partners, ELITech Molecular Diagnostics technologies are used in thousands of laboratories around the world.
ELITech Molecular Diagnostics superior assay performance and responsive customer support give us a leading position in the organ transplant market.